Effect of acute and chronic administration of the aqueous extract of Lawsonia inermis leaves on haloperidol induced catalepsy in albino mice

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 3, Issue 3, 2012, Pages 1107-1116

  Shastry, C S ^a   Kiran, U P ^a   Aswathanarayana, B J ^a  

^a NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

Catalepsy; Haloperidol; Lawsonia inermis Linn; Scopolamine

Indexed keywords

CARBOHYDRATE; CENTRAL NERVOUS SYSTEM AGENTS; FLAVANOID; LAWSONIA INERMIS EXTRACT; PLANT EXTRACT; SAPONIN; SUPEROXIDE DISMUTASE; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG RESPONSE; DRUG SCREENING; ENZYME ACTIVITY; LAWSONIA INERMIS; LONG TERM EXPOSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PLANT LEAF; TOXICITY TESTING;

ANIMALIA; LAWSONIA INERMIS; MUS;

EID: 84868007549     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Standaert DG, Young AB. Treatment of central nervous system degenerative disorders. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed, Mc Graw Hill, New York (NY), 2006. pp. 527.
2. Parkinson's disease. Available from: URL:http://www.lundbeck.com/global/braindisorders/diseaseareas/parkinsonsdisease.
3. Discovery could provide new treatment options for parkinson's disease. Available from: URL:http://www.elements4health.com/discovery-couldprovide-new-treatment-options-for-parkinsons-disease.html.
4. Bhutani KK, Gohil VM. Ind J Exp Biol 2010; 48: 199-207.
5. Borade AS, Kale BN, Shete RV. Int J Pharm Life Sci 2011; 2(1): 536-41.
6. Kamal M, Jawaid T. Int J Biomed Res 2010; 1(2): 37-43.
7. Hosein MHK, Zinab D. World J Dairy Food Sci 2007; 2(1): 38-41.
8. Sravanthi P, Kumar KM, Begum DT, Kumar SN, Ravindrareddy K, Khanhare RS. J Pharm Res 2011; 4(6): 1872-4.
9. Sanni S, Thilza IB, Ahmed MT, Sanni FS, Talle M, Okwor GO. Academia Arena 2010; 2(6): 87-9.
10. Sakarkar DM, Sakarkar UM, Shrikhande VN, Vyas JV, Mandavgade S, Jaiswal SB, et al. Nat Product Rad 2004; 3(6): 406-12.
11. Mikhaeil BR, Badria FA, Maatooq GT, Amer MA. Naturforsch 2004; 59: 468-76.
12. Arun P, Purushotham KG, Jayarani JJ, Kumara V. Int J PharmTech Res 2010; 2(2): 1178-81.
13. Zumrutdal ME, Ozaslan M, Tuzcu M, Kalender ME, Dagli{dotless}oglu K, Akova A. Afr J Biotechnol 2008; 7(16): 2781-6.
14. Rasheed AS, Venkataraman S, Jayaveera KN, Fazil AM, Yasodha KJ, Aleem MA, et al. Int J General Med 2010; 3: 127-36.
15. Berenji F, Rakshsandheh H, Ebrahimipour H. Jundishapur J Microbiol 2010; 3(3): 125-8.
16. Kokate CK, Purohit PA, Gokhale SB. Pharmacognosy Analytical pharmacognosy: a method of drug evaluation. 9th ed, Nirali Prakashan, Pune, 1998, pp. 92-3.
17. OECD/OCDE. 2001; 425: 1-26. Available from: URL:http://www.oecd.org/dataoecd/17/51/1948378.pdf
18. Gopalakrishna HN, Sudhakar P, Dorababu P, Pai MRSM, Colaco N, Vineetha V. J Clin Diagnos Res 2010; (4): 2134-8.
19. Nair V, Arjuman A, Dorababu P, Gopalakrishna HN, Rao UC, Mohan L. Ind J Med Res 2007; 126: 480-4.
20. Kono YA. Archives Biochem Biophy 1978; 186(1): 189-95.
21. Aswar MK, Joshi RH. Int J Pharm Res Develop 2010; 2(6): 1-7.
22. Arjuman A, Nair V, Gopalakrishna HN, Nandini M. Ind J Pharmacol 2007; 39(3): 151-4.
23. Ahemad RS, Venkataraman S, Mohammed, Fajayveera KN. Int J Pharm Pharmaceut Sci 2012; 4(3): 323-7.